Prime
Treatments
Testing and Advancements Index
The Prime Treatments, Testing and Advancements Index is designed to track both event-driven news and long-term trends of companies engaged in developing treatments and vaccines, or diagnostic technology, in the fight against infectious diseases.
FACT SHEET
Prime Treatments, Testing and Advancements Primer
PDF
Infectious Diseases: Prime Treatments, Testing and Advancements Overview
PDF
Prime Treatments, Testing and Advancements Index Methodology Guide
PDF
Prime Treatments, Testing and Advancements Factsheet
PDF
INDEX KEY FACTS
Base Date: December 12, 2019
Total number of holdings:
56
Launch date: June 08, 2020
Reconstitution: Quarterly (March, June, September and December)
Index calculation agent: Solactive AG
Weighting scheme: Modified Market Capitalization
INDEX SYMBOLS
| Version | Bloomberg | Reuters | ISIN |
|---|---|---|---|
| Prime Treatments, Testing and Advancements Index GTR | PGERM | .PGERMG | DE000SL0A030 |
| Prime Treatments, Testing and Advancements Index NTR | N/A | .PGERMN | DE000SL0A022 |
| Prime Treatments, Testing and Advancements Index PR | N/A | .PGERMP | DE000SL0A014 |
INDEX COMPOSITION
| Component Name | Ticker | Weight |
|---|---|---|
| NOVAVAX INC | NVAX | 10.91% |
| MODERNA INC | MRNA | 5.46% |
| EMERGENT BIOSOLUTIONS INC | EBS | 5.39% |
| QUIDEL CORP | QDEL | 5.32% |
| BIO-RAD LABORATORIES INC | BIO | 5.03% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | 4.83% |
| BIONTECH SE | BNTX | 4.76% |
| QUEST DIAGNOSTICS INC | DGX | 4.66% |
| LABORATORY CRP OF AMER HLDGS | LH | 4.55% |
| VIR BIOTECHNOLOGY INC | VIR | 4.07% |
| OPKO HEALTH INC | OPK | 4.03% |
| INOVIO PHARMACEUTICALS INC | INO | 3.90% |
| ZAI LAB LTD | ZLAB | 3.47% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 2.97% |
| I-MAB | IMAB | 1.92% |
| LUMINEX CORP | LMNX | 1.89% |
| DICERNA PHARMACEUTICALS INC | DRNA | 1.76% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 1.54% |
| MERIDIAN BIOSCIENCE INC | VIVO | 1.22% |
| NANTKWEST INC | NK | 1.20% |
| VBI VACCINES INC | VBIV | 1.17% |
| ORASURE TECHNOLOGIES INC | OSUR | 1.12% |
| ENANTA PHARMACEUTICALS INC | ENTA | 1.11% |
| DYNAVAX TECHNOLOGIES CORP | DVAX | 1.10% |
| ASSEMBLY BIOSCIENCES INC | ASMB | 0.93% |
| CO-DIAGNOSTICS INC | CODX | 0.88% |
| VAXART INC | VXRT | 0.84% |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 0.80% |
| CUE BIOPHARMA INC | CUE | 0.67% |
| IBIO INC | IBIO | 0.65% |
| SIGA TECHNOLOGIES INC | SIGA | 0.64% |
| ABBOTT LABORATORIES | ABT | 0.62% |
| ATHERSYS INC | ATHX | 0.60% |
| ASTRAZENECA PLC-SPONS ADR | AZN | 0.60% |
| PFIZER INC | PFE | 0.59% |
| REGENERON PHARMACEUTICALS | REGN | 0.58% |
| ELI LILLY & CO | LLY | 0.57% |
| SANOFI-ADR | SNY | 0.57% |
| JOHNSON & JOHNSON | JNJ | 0.56% |
| BRISTOL-MYERS SQUIBB CO | BMY | 0.56% |
| CEL-SCI CORP | CVM | 0.55% |
| MERCK & CO. INC. | MRK | 0.55% |
| ABBVIE INC | ABBV | 0.55% |
| TAKEDA PHARM-ADR | TAK | 0.54% |
| GLAXOSMITHKLINE PLC-SPON ADR | GSK | 0.54% |
| XBIOTECH INC | XBIT | 0.54% |
| GILEAD SCIENCES INC | GILD | 0.50% |
| OXFORD IMMUNOTEC GLOBAL PLC | OXFD | 0.45% |
| ARBUTUS BIOPHARMA CORP | ABUS | 0.37% |
| HOOKIPA PHARMA INC | HOOK | 0.32% |
| CHIMERIX INC | CMRX | 0.24% |
| PARATEK PHARMACEUTICALS INC | PRTK | 0.23% |
| CONTRAFECT CORP | CFRX | 0.16% |
| PHASEBIO PHARMACEUTICALS INC | PHAS | 0.15% |
| CORMEDIX INC | CRMD | 0.14% |
| ENZO BIOCHEM INC | ENZ | 0.14% |